Page last updated: 2024-08-26

4-hydroxycyclophosphamide and Hematologic Neoplasms

4-hydroxycyclophosphamide has been researched along with Hematologic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Broberg, U; Griskevicius, L; Hassan, M; Hassan, Z; Kimby, E; Rane, A; Ståhle, L; Xie, H; Yasar, U	1

Trials

1 trial(s) available for 4-hydroxycyclophosphamide and Hematologic Neoplasms

Article	Year
Pharmacogenetics of cyclophosphamide in patients with hematological malignancies. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2006, Volume: 27, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Aryl Hydrocarbon Hydroxylases; Bilirubin; Cyclophosphamide; Cytochrome P-450 CYP2B6; Female; Genotype; Hematologic Neoplasms; Humans; Liver; Male; Middle Aged; Models, Biological; Mutation; Oxidoreductases, N-Demethylating; Pharmacogenetics	2006

Article

Year

Pharmacogenetics of cyclophosphamide in patients with hematological malignancies.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2006, Volume: 27, Issue:1

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Aryl Hydrocarbon Hydroxylases; Bilirubin; Cyclophosphamide; Cytochrome P-450 CYP2B6; Female; Genotype; Hematologic Neoplasms; Humans; Liver; Male; Middle Aged; Models, Biological; Mutation; Oxidoreductases, N-Demethylating; Pharmacogenetics

2006